actinium pharmaceuticals inc
(ATNM:Consolidated issues listed on NYSE MKT LLC)
Geraldine A. Henwood Ph.D.
Chief Development Officer of Iomab-B, Actinium Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 24 board members in 4 different organizations across 8 different industries.|
See Board Relationships
Dr. Geraldine A. Henwood, also known as Gerri, Ph.D., has been the Chief Development Officer of Iomab-B at Actinium Pharmaceuticals, Inc. since September 2012. Dr. Henwood has been the Chief Executive Officer of Garnet Biotherapeutics, Inc. since November 2008. She has been the Chief Executive Officer and President of RECRO Pharma, Inc. since 2008. She is a Venture Partner at SCP Vitalife. She is the Founder of Malvern Consulting Group and served as its President from ...
546 Fifth AvenuePhone: 646-459-4201
New York, New York 10036
Board Members Memberships*
Chief Executive Officer and Director
Chief Executive Officer, President and Director
Director and Member of Compensation Committee
|There is no Competitor Compensation data available.|